News

Rheonova attend the ATS 2024

Rheonova attend the ATS 2024

We are happy to share that Rheonova participated in the ATS (American Thoracic Society) conference held at the San Diego International Convention Center from May 19 to 22, 2024. During this internationnal congress we showcased a poster discussing a preliminary study...

read more
North American Cystic Fibrosis Conference 2023

North American Cystic Fibrosis Conference 2023

Rheonova was present at the NACFC 2023 held in Phoenix, Arizona from Nov 2nd to Nov 4th. Our colleague Lama Soueidan was happy to present our latest work on sputum rheology titled: "Sputum from CF and non-CF obstructive diseases: similarities and differences". Contact...

read more
Rheonova will be present at the ATS 2023

Rheonova will be present at the ATS 2023

Rheonova will be exhibiting at the American Thoracic Society Conference 2023 held at Walter E. Washington Convention Center in Washington DC From May 19th to May 24th. Stop by our booth N°2620 to check Rheomuco and discuss with our experts about mucus rheology and how...

read more
Rheonova participated at ECFS basic Science 2022

Rheonova participated at ECFS basic Science 2022

Rheonova was present at the ECFS basic science 2022 at Albufeira. Our PhD student Lydia ESTEBAN ENJUTO presented her work on cystic fibrosis sputum handling for rheology. Muco-obstructive diseases, including cystic fibrosis, COPD or severe asthma feature an alteration...

read more
Rheomuco CE marking funding

Rheomuco CE marking funding

Rheonova is supported by the Auvergne Rhône-Alpes region to ensure compliance with the new European regulation for CE marking of our medical device Rheomuco and the associated quality management system. The region, in collaboration with the Agency, Lyonbiopole and...

read more
BronchoClogDrain : A new innovative research project

BronchoClogDrain : A new innovative research project

Rheonova is pleased to inform you that the research project BronchoClogDrain has received funding from the French National Research Agency (ANR). This project brings together various academic and private stakeholders focusing on obstructive lung diseases, specifically...

read more
Rheonova participated to CPLF 2022

Rheonova participated to CPLF 2022

Rheonova was present at the Congrès de Pneumologie de Langue Française 2022 in Lille where we presented our latest work on bronchial mucus heterogeinity: micro- and macro-rheology study Abstract In lung muco-obstructive diseases, such as cystic fibrosis, chronic...

read more
Happy New Year 2022!

Happy New Year 2022!

Rheonova wishes you happy new year 2022!this past year have been rich, challenging and exciting, here is a small preview!

read more
Rheonova granted the first regional PSPC

Rheonova granted the first regional PSPC

We are happy to announce that Rheonova, in collaboration with Cedrat Technologies and the laboratories TIMA and LRP, have been granted the regional PSPC for the project MucoPiezoRheo. This project aims to develop a medical device for personalized diagnosis and...

read more
Rheonova among the “Concours Innovation” winners

Rheonova among the “Concours Innovation” winners

Winner of the "Concours Innovation", Rheonova will continue the clinical validation for a diagnostic test for Cystic Fibrosis. A financial aid of 352.000 € for the MucoCF project using the medical device Rheomuco® For the press release, click here

read more
Meet Rheonova at the Francophone Cystic Fibrosis Days!

Meet Rheonova at the Francophone Cystic Fibrosis Days!

Rheonova will be present at the 3rd Francophone Day of Cystic Fibrosis, Lyon, April 5th-7th 2018. Every 2 years, patients and health professionals meet together during this event organized by Vaincre la Mucoviscidose and by the French Society of Cystic Fibrosis (SFM)....

read more

Rheonova organizes demonstrations of Rheomuco!

You are working on respiratory diseases such as cystic fibrosis, COPD or asthma? Demonstrations of Rheomuco are regularly organized on our site, on the sites of our partners or on your premises. Contact us to learn more about Rheomuco's apps!

read more
Rheonova, laureate of the 19th i-LAB

Rheonova, laureate of the 19th i-LAB

Respiratory diseases will become the third leading cause of death in 2020 according to WHO, due to pollution and tobacco. The Rheomuco device developed by Rheonova is aimed at researchers and health professionals. It helps the evaluation of treatments and the...

read more